Table 1

 Baseline characteristics of patients with RA

TreatmentMTX group (n = 20)SSZ group (n = 37)AUR group (n = 19)p Value*
*Analysis of variance followed by post hoc Bonferroni’s test; †based on a 28 joints count; ‡estimated by a visual analogue 0–100 scale.
Demographic characteristics
Age (years), mean (SD)63.0 (12.4)54.0 (16.8)59.1 (13.0)0.1
Male, No (%)6 (30)18 (49)7 (37)
Female, No (%)14 (70)19 (51)12 (63)
Disease duration (months), mean (SEM)5.6 (0.6)7.1 (0.7)6.9 (0.8)0.3
Clinical baseline values, mean (SEM)
ESR (mm/1st h)24.4 (3.8)25.7 (3.7)16.3 (2.2)0.2
CRP (mg/l)26.7 (6.0)15.4 (1.8)11.2 (2.2)0.01
DAS284.9 (0.3)4.6 (0.2)4.1 (0.2)0.06
HAQ1.1 (0.1)0.6 (0.8)0.8 (0.1)0.01
Swollen joint count†8.8 (1.3)10.4 (0.9)4.5 (0.8)0.001
Tender joint count†8.5 (1.5)7.0 (0.9)4.6 (0.9)0.1
Pain‡50.5 (6.1)35.8 (3.4)39.0 (5.9)0.08
Global assessment of disease activity‡40.6 (5.3)34.0 (4.0)43.6 (5.6)0.3
Larsen score16.4 (2.7)13.2 (1.8)9.6 (1.7)0.1